Annual EPS
-$73.50
+$48.75+39.88%
December 31, 2023
Summary
- As of February 7, 2025, ATXI annual earnings per share is -$73.50, with the most recent change of +$48.75 (+39.88%) on December 31, 2023.
- During the last 3 years, ATXI annual EPS has risen by +$275.25 (+78.92%).
- ATXI annual EPS is now at all-time high.
Performance
ATXI EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$1.92
+$4.51+70.14%
September 30, 2024
Summary
- As of February 7, 2025, ATXI quarterly earnings per share is -$1.92, with the most recent change of +$4.51 (+70.14%) on September 30, 2024.
- Over the past year, ATXI quarterly EPS has dropped by -$3.80 (-202.39%).
- ATXI quarterly EPS is now -121.25% below its all-time high of $9.03, reached on December 31, 2022.
Performance
ATXI Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$21.87
-$6.78-44.92%
September 30, 2024
Summary
- As of February 7, 2025, ATXI TTM earnings per share is -$21.87, with the most recent change of -$6.78 (-44.92%) on September 30, 2024.
- Over the past year, ATXI TTM EPS has increased by +$111.70 (+83.62%).
- ATXI TTM EPS is now -44.92% below its all-time high of -$15.09, reached on June 30, 2024.
Performance
ATXI TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
ATXI EPS Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +39.9% | -202.4% | +83.6% |
3 y3 years | +78.9% | +96.5% | +91.2% |
5 y5 years | +96.9% | +98.8% | +98.0% |
ATXI EPS Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +70.2% | -121.3% | +98.8% | -44.9% | +93.5% |
5 y | 5-year | at high | +96.0% | -121.3% | +99.5% | -44.9% | +98.9% |
alltime | all time | at high | +96.9% | -121.3% | +99.8% | -44.9% | +99.3% |
Avenue Therapeutics EPS History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$1.92(-70.1%) | -$21.87(+44.9%) |
Jun 2024 | - | -$6.43(-58.2%) | -$15.09(-68.2%) |
Mar 2024 | - | -$15.40(-921.2%) | -$47.40(-64.5%) |
Dec 2023 | -$73.50(-39.9%) | $1.88(-61.4%) | -$133.57(+5.7%) |
Sep 2023 | - | $4.86(-112.5%) | -$126.42(-23.4%) |
Jun 2023 | - | -$38.74(-61.9%) | -$165.03(+5.1%) |
Mar 2023 | - | -$101.57(-1224.4%) | -$157.04(-24.9%) |
Dec 2022 | -$122.25(-50.5%) | $9.03(-126.8%) | -$209.22(-23.6%) |
Sep 2022 | - | -$33.75(+9.8%) | -$273.75(-8.5%) |
Jun 2022 | - | -$30.75(-80.0%) | -$299.25(-10.9%) |
Mar 2022 | - | -$153.75(+177.0%) | -$336.00(+34.5%) |
Dec 2021 | -$246.75(-29.2%) | -$55.50(-6.3%) | -$249.75(-4.6%) |
Sep 2021 | - | -$59.25(-12.2%) | -$261.75(-3.1%) |
Jun 2021 | - | -$67.50(0.0%) | -$270.00(-17.2%) |
Mar 2021 | - | -$67.50(0.0%) | -$326.25(-6.5%) |
Dec 2020 | -$348.75 | -$67.50(0.0%) | -$348.75(-46.6%) |
Sep 2020 | - | -$67.50(-45.5%) | -$652.50(-12.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2020 | - | -$123.75(+37.5%) | -$742.50(-32.7%) |
Mar 2020 | - | -$90.00(-75.8%) | -$1102.50(-43.0%) |
Dec 2019 | -$1856.25(-21.4%) | -$371.25(+135.7%) | -$1935.00(-2.3%) |
Sep 2019 | - | -$157.50(-67.4%) | -$1980.00(-5.9%) |
Jun 2019 | - | -$483.75(-47.6%) | -$2103.75(-1.1%) |
Mar 2019 | - | -$922.50(+121.6%) | -$2126.25(-10.0%) |
Dec 2018 | -$2362.50(+13.5%) | -$416.25(+48.0%) | -$2362.50(-11.0%) |
Sep 2018 | - | -$281.25(-44.4%) | -$2655.00(-2.1%) |
Jun 2018 | - | -$506.25(-56.3%) | -$2711.25(-9.4%) |
Mar 2018 | - | -$1158.75(+63.5%) | -$2992.50(+56.8%) |
Dec 2017 | -$2081.25(+414.8%) | -$708.75(+110.0%) | -$1908.03(+46.4%) |
Sep 2017 | - | -$337.50(-57.1%) | -$1302.98(+25.9%) |
Jun 2017 | - | -$787.50(+960.2%) | -$1034.70(+199.6%) |
Mar 2017 | - | -$74.28(-28.4%) | -$345.30(-14.6%) |
Dec 2016 | -$404.25 | -$103.70(+49.8%) | -$404.25(+34.5%) |
Sep 2016 | - | -$69.22(-29.4%) | -$300.55(+29.9%) |
Jun 2016 | - | -$98.10(-26.4%) | -$231.33(+73.6%) |
Mar 2016 | - | -$133.22 | -$133.22 |
FAQ
- What is Avenue Therapeutics annual earnings per share?
- What is the all time high annual EPS for Avenue Therapeutics?
- What is Avenue Therapeutics annual EPS year-on-year change?
- What is Avenue Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Avenue Therapeutics?
- What is Avenue Therapeutics quarterly EPS year-on-year change?
- What is Avenue Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Avenue Therapeutics?
- What is Avenue Therapeutics TTM EPS year-on-year change?
What is Avenue Therapeutics annual earnings per share?
The current annual EPS of ATXI is -$73.50
What is the all time high annual EPS for Avenue Therapeutics?
Avenue Therapeutics all-time high annual earnings per share is -$73.50
What is Avenue Therapeutics annual EPS year-on-year change?
Over the past year, ATXI annual earnings per share has changed by +$48.75 (+39.88%)
What is Avenue Therapeutics quarterly earnings per share?
The current quarterly EPS of ATXI is -$1.92
What is the all time high quarterly EPS for Avenue Therapeutics?
Avenue Therapeutics all-time high quarterly earnings per share is $9.03
What is Avenue Therapeutics quarterly EPS year-on-year change?
Over the past year, ATXI quarterly earnings per share has changed by -$3.80 (-202.39%)
What is Avenue Therapeutics TTM earnings per share?
The current TTM EPS of ATXI is -$21.87
What is the all time high TTM EPS for Avenue Therapeutics?
Avenue Therapeutics all-time high TTM earnings per share is -$15.09
What is Avenue Therapeutics TTM EPS year-on-year change?
Over the past year, ATXI TTM earnings per share has changed by +$111.70 (+83.62%)